Clinical Trial Update: Rapid Switch From Flolan to Remodulin in the Outpatient Clinic [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating a rapid switch from Flolan to Remodulin in an outpatient clinic settings; the study is terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• FLOLAN (EPOPROSTENOL SODIUM)
• Remodulin (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Hypertension, Pulmonary | Phase 4 | Status: TERMINATED | Results posted: 2013-06-21